Literature DB >> 19191656

Tuberculosis immune reconstitution inflammatory syndrome: drug resistance and the critical need for better diagnostics.

Gerald Friedland.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19191656     DOI： 10.1086/596765

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

Review 1.  Management of individuals requiring antiretroviral therapy and TB treatment.

Authors:  Karen Cohen; Graeme Meintjes
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

2.  Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; Robert J Wilkinson; Chelsea Morroni; Dominique J Pepper; Kevin Rebe; Molebogeng X Rangaka; Tolu Oni; Gary Maartens
Journal:  AIDS       Date:  2010-09-24       Impact factor: 4.177

Review 3.  Effects of time of initiation of antiretroviral therapy in the treatment of patients with HIV/TB co-infection: A systemic review and meta-analysis.

Authors:  Legese Chelkeba; Ginenus Fekadu; Gurmu Tesfaye; Firehiwot Belayneh; Tsegaye Melaku; Zeleke Mekonnen
Journal:  Ann Med Surg (Lond)       Date:  2020-05-16

4.  Case Report: Suspected Case of Brucella-Associated Immune Reconstitution Inflammatory Syndrome.

Authors:  Chunmei Qu; Nannan Xu; Dehong Niu; Sai Wen; Hui Yang; Shanshan Wang; Gang Wang
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.